Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 7, 2024; 30(13): 1899-1910
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1899
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1899
Parameter | Crohn’s disease (n = 48) | Ulcerative colitis (n = 42) | P value1 |
Basic characteristics | |||
Age, yr | 40.7 ± 16.0 | 42.7 ± 15.9 | 0.567 |
Male sex, n (%) | 31 (64.6) | 22 (52.4) | 0.243 |
Body mass index, kg/m2 | 23.2 ± 3.6 | 23.9 ± 4.9 | 0.459 |
Waist-to-hip ratio | 0.86 ± 0.08 | 0.86 ± 0.08 | 0.495 |
Hypertension, n (%) | 2 (4.2) | 4 (9.5) | 0.312 |
Dyslipidemia, n (%) | 3 (6.2) | 4 (9.5) | 0.565 |
Family history of IBD, n (%) | 10 (20.8) | 6 (14.3) | 0.420 |
Family history of CRC, n (%) | 10 (20.8) | 7 (16.7) | 0.616 |
Family history of CVD, n (%) | 12 (28.6) | 17 (35.4) | 0.491 |
Smoking, n (%) | 16 (33.3) | 1 (2.4) | < 0.001 |
Laboratory parameters | |||
C-reactive protein, mg/L | 1.9 (0.6-7.6) | 1.4 (0.8-2.2) | 0.153 |
Serum iron, μmol/L | 14.6 ± 7.6 | 16.5 ± 7.9 | 0.247 |
Albumins, g/L | 39.5 ± 5.5 | 41.6 ± 3.6 | 0.018 |
Fasting blood glucose, mmol/L | 4.9 ± 0.8 | 5.6 ± 2.5 | 0.100 |
Total cholesterol, mmol/L | 4.4 ± 1.2 | 5.1 ± 1.3 | 0.005 |
LDL-C, mmol/L | 2.3 ± 0.9 | 3.1 ± 1.1 | < 0.001 |
HDL-C, mmol/L | 1.3 ± 0.4 | 1.4 ± 0.4 | 0.045 |
Triglycerides, mmol/L | 1.7 ± 1.5 | 1.2 ± 0.7 | 0.079 |
Disease characteristics | |||
Disease duration, yr | 7 (3-14) | 9 (5-13) | 0.397 |
IBD-related surgery, n (%) | 20 (41.7) | 0 (0.0) | < 0.001 |
ExtraintestiN/Al manifestations, n (%) | 27 (56.3) | 7 (16.7) | < 0.001 |
SES-CD | 10 (5-13) | N/A | N/A |
CDAI | 55 (34-84) | N/A | N/A |
UCEIS | N/A | 5.0 (1.5-6.5) | |
Mayo/DAI | N/A | 3 (2-5) | N/A |
Fecal calprotectin, μg/g | 232 (80-589) | 85 (10-246) | 0.009 |
Therapy, n (%) | |||
Aminosalicylates | 22 (45.8) | 23 (54.8) | 0.421 |
DMARDs | 18 (37.5) | 17 (40.5) | 0.826 |
MonocloN/Al antibodies | 36 (75.0) | 32 (76.2) | 0.896 |
- Citation: Tonkic A, Kumric M, Akrapovic Olic I, Rusic D, Zivkovic PM, Supe Domic D, Sundov Z, Males I, Bozic J. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease. World J Gastroenterol 2024; 30(13): 1899-1910
- URL: https://www.wjgnet.com/1007-9327/full/v30/i13/1899.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i13.1899